title: Screening for Mycobacterium tuberculosis prior to anti-TNF therapy--an audit of impact of the British Thoracic Society guidelines on rheumatology practice in an area of low Mycobacterium tuberculosis prevalence.
authors.forename: J D
authors.initials: JD
authors.lastname: Pradeep
authors.forename: G P R
authors.initials: GP
authors.lastname: Clunie
authors.forename: K
authors.initials: K
authors.lastname: Gaffney
authors.forename: N J
authors.initials: NJ
authors.lastname: Innes
authors.forename: A
authors.initials: A
authors.lastname: Brooksby
authors.forename: P
authors.initials: P
authors.lastname: Bradley
authors.forename: A
authors.initials: A
authors.lastname: Gulati
mesh_terms: D004739:England; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification*; D017410:Practice Guidelines as Topic; D012219:Rheumatology; D014376:Tuberculosis / Q000175:diagnosis*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha